T1	Endpoint 25 44	imals and treatment
T2	TestArticle 55 73	adult (60-day-old)
T3	Strain 74 88	Sprague-Dawley
T4	Sex 89 93	male
T5	Sex 98 104	female
T6	Species 105 109	rats
T7	Species 487 491	Rats
T8	TestArticle 526 537	rolled cond
T9	DoseFrequency 749 759	ad libitum
T10	Sex 761 765	Male
T11	Sex 770 776	female
T12	Species 777 781	rats
T13	TimeEndpointAssessed 903 908	daily
T14	GroupSize 944 949	eight
T15	Sex 956 962	female
T16	Species 963 967	rats
T17	TestArticle 987 994	rd cond
T18	Vehicle 1011 1025	tap water cont
T19	Vehicle 1030 1043	g 2% Tween 80
T20	DoseRoute 1057 1062	drink
T21	DoseRoute 1064 1074	g solution
T22	DoseDuration 1079 1081	30
T23	DoseDurationUnits 1082 1086	days
T24	GroupName 1100 1117	baseline controls
T25	Endpoint 1232 1241	cyclicity
T26	Species 1245 1249	rats
T27	Sex 1256 1260	male
T28	Sex 1264 1270	female
T29	Endpoint 1271 1286	sexual behavior
T30	GroupName 1299 1317	tap water controls
T31	Sex 1400 1406	female
T32	Species 1407 1411	rats
T33	TestArticle 1444 1471	9,10-dihy-droxy-12-octadece
T34	TestArticle 1473 1489	ic acid [leukoto
T35	Endpoint 1493 1497	diol
T36	TestArticle 1499 1504	LTX-d
T37	TestArticle 1505 1509	ol)]
T38	Dose 1519 1520	2
T39	DoseUnits 1521 1526	 g/mL
T40	DoseRoute 1535 1544	tap water
T41	Vehicle 1545 1553	Tween 80
T42	DoseDuration 1580 1582	30
T43	DoseDurationUnits 1583 1587	days
T44	TestArticle 1717 1720	ols
T45	TimeEndpointAssessed 1795 1800	Daily
T46	DoseDuration 1846 1848	30
T47	DoseDurationUnits 1849 1852	day
T48	Endpoint 1888 1897	cyclicity
T49	Sex 1987 1993	female
T50	Species 1994 1998	rats
T51	GroupName 2019 2027	controls
T52	Endpoint 2042 2056	ovarian cycles
T53	TestArticle 2090 2095	LTX-d
T54	GroupName 2220 2228	controls
T55	GroupName 2232 2247	treated animals
T56	GroupName 2285 2293	controls
T57	Endpoint 2372 2395	male reproductive funct
T58	DoseRoute 2395 2398	ion
T59	GroupSize 2434 2437	six
T60	Sex 2456 2460	male
T61	Strain 2461 2475	Sprague-Dawley
T62	Species 2484 2488	rats
T63	TestArticle 2535 2541	THF-di
T64	Sex 2608 2612	male
T65	Species 2621 2625	rats
T66	DoseRoute 2757 2774	drinking solution
T67	TestArticle 2786 2791	LTX-d
T68	TestArticle 2792 2802	ol isomers
T69	DoseUnits 2803 2813	(2 g/mL of
T70	DoseRoute 2814 2819	drink
T71	DoseRoute 2821 2830	g solutio
T72	DoseDuration 2837 2840	1 4
T73	DoseDurationUnits 2841 2846	weeks
T74	Endpoint 2848 2863	Sexual behavior
T75	EndpointUnitOfMeasure 2897 2901	mber
T76	Endpoint 2902 2911	of mounts
T77	Endpoint 2922 2958	ions, ejaculations, ejaculation late
T78	EndpointUnitOfMeasure 2968 2975	seconds
T79	Endpoint 2982 2990	grooming
T80	EndpointUnitOfMeasure 2991 2998	frequen
T81	Sex 3056 3062	female
T82	Strain 3168 3182	Sprague-Dawley
T83	Sex 3183 3189	female
T84	Species 3190 3194	rats
T85	DoseRoute 3294 3297	ect
T86	TestArticle 3498 3505	ic acid
T87	TestArticle 3510 3518	m-chloro
T88	DoseRoute 4541 4544	ect
T89	Endpoint 4656 4666	c activity
T90	CellLine 4670 4675	MCF-7
T91	Endpoint 4706 4743	c effects of HPLC fractions and synth
T92	TestArticle 4748 4753	LTX-d
T93	TestArticle 4754 4756	ol
T94	CellLine 4760 4765	MCF-7
T95	Species 4766 4771	human
T96	Endpoint 4816 4822	mitoge
T97	CellLine 4868 4873	MCF-7
T98	Dose 5011 5014	1 5
T99	DoseUnits 5015 5017	 L
T100	TestArticle 5046 5051	LTX-d
T101	TestArticle 5053 5062	l isomers
T102	Vehicle 5066 5085	redistilled ethanol
T103	CellLine 5098 5103	MCF-7
T104	Endpoint 5203 5227	ipped, sulfatase-treated
T105	Species 5228 5238	fetal calf
T106	Endpoint 5246 5252	Cell n
T107	Endpoint 5255 5257	er
T108	TimeEndpointAssessed 5273 5274	7
T109	TimeUnits 5275 5279	days
T110	Endpoint 5446 5452	mitoge
T111	Endpoint 5454 5464	c activity
T112	TestArticle 5731 5736	LTX-d
T113	TestArticle 5744 5751	12,13-d
T114	TestArticle 5753 5771	y-droxy-9-octadece
T115	TestArticle 5773 5780	ic acid
T116	TestArticle 5782 5795	iso-LTX-diol)
T117	Vehicle 5821 5840	redistilled ethanol
T118	Endpoint 5895 5909	GC-MS analysis
T119	Endpoint 6469 6472	ion
T120	TestArticle 6748 6750	ol
T121	DoseRoute 7274 7277	ect
T122	TestArticle 7757 7767	2-octadece
T123	TestArticle 7776 7798	12,13-epoxy-9-octadece
T124	TestArticle 7941 7948	ic acid
T125	TestArticle 8334 8339	LTX-d
T126	TestArticle 8340 8342	ol
T127	TestArticle 8347 8356	iso-LTX-d
T128	TestArticle 8357 8360	ol.
T129	Endpoint 8368 8375	imately
T130	TestArticle 8591 8596	LTX-d
T131	TestArticle 8597 8599	ol
T132	TestArticle 8604 8613	iso-LTX-d
T133	TestArticle 8614 8616	ol
T134	TestArticle 8643 8650	ic acid
T135	TestArticle 8655 8660	THF-d
T136	TestArticle 9132 9142	THF-diols.
T137	TestArticle 9236 9241	LTX-d
T138	TestArticle 9242 9244	ol
T139	TestArticle 9249 9258	iso-LTX-d
T140	TestArticle 9259 9262	ol.
T141	TestArticle 9390 9398	LTX-diol
T142	Endpoint 9452 9464	and contamin
T143	TestArticle 9545 9550	LTX-d
T144	TestArticle 9551 9553	ol
T145	TestArticle 9558 9567	iso-LTX-d
T146	TestArticle 9568 9571	ol.
T147	Endpoint 9588 9607	biologic activities
T148	TestArticle 9642 9647	LTX-d
T149	TestArticle 9648 9650	ol
T150	TestArticle 9655 9664	iso-LTX-d
T151	TestArticle 9665 9667	ol
T152	TestArticle 10030 10039	iso-LTX-d
T153	TestArticle 10040 10042	ol
T154	TestArticle 10047 10056	LTX-diol,
T155	TestArticle 10083 10088	LTX-d
T156	TestArticle 10089 10091	ol
T157	TestArticle 10096 10105	iso-LTX-d
T158	CellLine 10112 10117	MCF-7
T159	Endpoint 10132 10150	cell proliferation
T160	TestArticle 10157 10162	LTX-d
T161	TestArticle 10163 10173	ol isomers
T162	Endpoint 10310 10328	cell proliferation
T163	CellLine 10365 10370	MCF-7
T164	TestArticle 10431 10455	LTX-diol or iso-LTX-diol
T165	Dose 10472 10478	0.1 10
T166	DoseUnits 10479 10484	 g/mL
T167	Endpoint 10491 10495	cell
T168	EndpointUnitOfMeasure 10496 10502	number
T169	TimeEndpointAssessed 10518 10519	7
T170	TimeUnits 10520 10524	days
T171	Endpoint 10628 10645	biologic activity
T172	CellLine 10653 10658	MCF-7
T173	Endpoint 10659 10677	cell proliferation
T174	TestArticle 10745 10750	LTX-d
T175	Endpoint 10750 10774	iol competition for [3H]
T176	TestArticle 10781 10783	ol
T177	Endpoint 10784 10830	binding to ER and type II sites in rat uterine
T178	Endpoint 10832 10848	uclear fractions
T179	Endpoint 10905 10917	xtracts cont
T180	Endpoint 10928 10934	mitoge
T181	Endpoint 10935 10946	ic activity
T182	TestArticle 11011 11013	ol
T183	Endpoint 11014 11019	bindi
T184	TestArticle 11058 11060	ol
T185	Endpoint 11061 11066	bindi
T186	TestArticle 11137 11142	THF-d
T187	TestArticle 11143 11145	ol
T188	Endpoint 11209 11225	biologic effects
T189	TestArticle 11233 11238	LTX-d
T190	TestArticle 11239 11242	ols
T191	Endpoint 11316 11337	nuclear type II sites
T192	TestArticle 11350 11355	LTX-d
T193	TestArticle 11356 11359	ols
T194	TestArticle 11392 11402	THF-diols.
T195	TestArticle 11457 11462	LTX-d
T196	Endpoint 11462 11486	iol competition for [3H]
T197	TestArticle 11493 11495	ol
T198	Endpoint 11496 11526	binding to ER or type II sites
T199	Sex 11577 11583	female
T200	Strain 11584 11598	Sprague-Dawley
T201	Species 11599 11603	rats
T202	TestArticle 11647 11660	g estradiol-c
T203	TimeEndpointAssessed 11782 11787	Seven
T204	TimeUnits 11788 11792	days
T205	Endpoint 11814 11846	uteri were removed from these an
T206	Endpoint 11853 11892	stripped of extraneous tissues, weighed
T207	Endpoint 11946 11988	ER competition studies, rat uterine tissue
T208	TestArticle 12194 12199	LTX-d
T209	TestArticle 12200 12202	ol
T210	Endpoint 12266 12270	[3H]
T211	TestArticle 12277 12279	ol
T212	Endpoint 12280 12294	binding to ERs
T213	TestArticle 12540 12545	LTX-d
T214	TestArticle 12546 12548	ol
T215	Endpoint 12616 12626	under cond
T216	Endpoint 12646 12650	[3H]
T217	TestArticle 12657 12659	ol
T218	Endpoint 12660 12684	binding to type II sites
T219	TestArticle 12943 12946	ol.
T220	Endpoint 12947 12973	Radioactivity in the ethan
T221	Endpoint 12977 12983	xtract
T222	Endpoint 13063 13069	[3H]Es
T223	TestArticle 13074 13076	ol
T224	Endpoint 13077 13081	bind
T225	Endpoint 13088 13134	the absence of competitor (controls) was appro
T226	Endpoint 13145 13172	,000 cpm for ERs and 30,000
T227	EndpointUnitOfMeasure 13173 13176	cpm
T228	Endpoint 13177 13194	for type II sites
T229	EndpointUnitOfMeasure 13226 13239	percentage of
T230	Endpoint 13240 13244	[3H]
T231	Endpoint 13250 13257	iol bou
T232	Endpoint 13288 13301	ated concentr
T233	TestArticle 13311 13316	LTX-d
T234	Endpoint 13317 13337	ol, DES, or luteolin
T235	EndpointUnitOfMeasure 13338 13369	relative to the vehicle control
T236	Endpoint 13424 13442	cell proliferation
T237	Endpoint 13456 13490	imal cycling studies (body weights
T238	Endpoint 13492 13506	fluid consumpt
T239	Sex 13699 13703	male
T240	Endpoint 13704 13719	sexual behavior
